Skip to main content

Advertisement

SpringerLink
Log in

Menstrual migraine: treatment options

  • SESSION II MIGRAINE IN WOMEN
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

More than half of women with migraine note an association of headache attacks and their menstrual cycles. Headaches associated with menses are often more severe and disabling than headaches that occur other times of the month. First-line therapies include acute agents used for migraine in general; however, for many women, these therapies provide incomplete relief. In these situations, treatment options include short-term perimenstrual prevention employing nonsteroidal anti-inflammatory medications, triptans, or hormone-containing preparations. Should these options not suffice, or if menstrual cycles are irregular, continuous prevention using hormonal therapies or standard anti-migraine prophylaxis should be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lipton RB, Stewart WF, Diamond S et al (2001) Prevalence and burden of migraine in the United States; data from the American Migraine Study II. Headache 41:646–657

    Article  CAS  PubMed  Google Scholar 

  2. Stewart WF, Lipton RB, Chee E, Sawyer J, Silberstein SD (2000) Menstrual cycle and headache in a population sample of migraineurs. Neurology 55:1517–1523

    Article  CAS  PubMed  Google Scholar 

  3. Martin V (2004) Menstrual migraine: a review of prophylactic therapies. Curr Pain Headache Rep 8:229–237

    Article  PubMed  Google Scholar 

  4. Johannes CB, Linet MS, Stewart WF, Celentano DD, Lipton RB, Szklo M (1995) Relationship of headache to phase of the menstrual cycle among young women: a daily diary study. Neurology 45:1076–1082

    Article  CAS  PubMed  Google Scholar 

  5. Calhoun AH, Hutchinson S (2009) Hormonal therapies for menstrual migraine. Curr Pain Headache Rep 13:381–385

    Article  PubMed  Google Scholar 

  6. Ventik KG, MacGregor EA, Lundquist C et al (2010) Self-reported menstrual migraine in the general population. Pain 11:87–92

    Article  Google Scholar 

  7. MacGregor EA, Hackshaw A (2004) Prevalence of migraine on each day of the natural menstrual cycle. Neurology 63:351–353

    Article  PubMed  Google Scholar 

  8. MacGregor EA (2012) Classification of perimenstrual headache: clinical relevance. Curr Pain Headache Rep 16:452–460

    Article  PubMed  Google Scholar 

  9. Somerville BW (1971) The role of progesterone in menstrual migraine. Neurology 21:853–859

    Article  CAS  PubMed  Google Scholar 

  10. Benedetto C, Allais G, Ciochetto D et al (1997) Pathophysiological aspects of menstrual migraine. Cephalalgia 17(suppl 20):32–34

    PubMed  Google Scholar 

  11. MacGregor EA (2009) Menstrual migraine: therapeutic approaches. Ther Adv Neurol Disord 2:327–336

    Article  PubMed Central  PubMed  Google Scholar 

  12. Couturier EG, Bombof MA, Neven AK et al (2003) Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia 23:302–308

    Article  CAS  PubMed  Google Scholar 

  13. Martin VT, Wernke S, Mandell K et al (2005) Defining the relationship between ovarian hormones and migraine headache. Headache 45:1190–1201

    Article  PubMed  Google Scholar 

  14. Sullivan E, Bushnell C (2010) Management of menstrual migraine: a review of current abortive and prophylactic therapies. Curr Pain Headache Rep 14:376–384

    Article  PubMed Central  PubMed  Google Scholar 

  15. Vetvik KG, Russell MB (2011) Are menstrual and nonmenstrual migraine different? Curr Pain Headache Rep 15:339–342

    Article  PubMed Central  PubMed  Google Scholar 

  16. Granella F, Sances G, Allais G et al (2004) Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centers. Cephalalgia 24:707–716

    Article  CAS  PubMed  Google Scholar 

  17. Headache Classification Committee of the International Headache Society (IHS) (2013) The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 33:629–808

    Article  Google Scholar 

  18. Loder E, Silberstein SD, Abu-Shakra S, Mueller L, Smith T (2004) Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study. Headache 44:120–130

    Article  PubMed  Google Scholar 

  19. Newman LC, Harper S, Jones BA, Campbell J (2009) Frovatriptan for acute treatment of migraine associated with menstruation: results from an open-label postmarketing surveillance study. J Womans Health 18:1265–1273

    Article  Google Scholar 

  20. Allais G, Acuto G, Cabarrocas X, Esbri R, Benedetto C, Bussone G (2006) Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine. Neurol Sci 27(Suppl. 2):S193–S197

    Article  PubMed  Google Scholar 

  21. Allais G, Bussone G, De Lorenzo C et al (2007) Naproxen sodium in short-term prophylaxis of pure menstrual migraine: pathophysiological and clinical considerations. Neurol Sci 28(Suppl 2):S225–S228

    Article  PubMed  Google Scholar 

  22. Sances G, Martignoni E, Fioroni L, Blandini F, Facchinetti F, Nappi G (1990) Naproxen sodium in menstrual migraine prophylaxis: a double-blind placebo controlled study. Headache 30:705–709

    Article  CAS  PubMed  Google Scholar 

  23. Newman LC, Lipton RB, Lay CL, Solomon S (1998) A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine. Neurology 51:307–309

    Article  CAS  PubMed  Google Scholar 

  24. Moschiano F, Allais G, Grazzi L, Usai S, Benedetto C, D’Amico D et al (2005) Naratriptan in the short-term prophylaxis of pure menstrual migraine. Neurol Sci 26(Suppl 2):s162–s166

    Article  PubMed  Google Scholar 

  25. Newman L, Mannix LK, Landy S, Silberstein S, Lipton RB, Putnam DG et al (2001) Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. Headache 41:248–256

    Article  CAS  PubMed  Google Scholar 

  26. Allais G, Tullo V, Omboni S et al (2013) Frovatriptan vs other triptans in the treatment of menstrual migraine: pooled analysis of three double-blind, randomized, cross-over studies. J Headache Pain 14(Suppl 1):191

    Article  Google Scholar 

  27. Hu Y, Guan X, Fan L et al (2013) Triptans in prevention of menstrual migraine: a systematic review with meta-analysis. J Headache Pain 14:7–15

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  28. Guidotti M, Mauri M, Barrila C, Guidotti F, Belloni C (2007) Frovatriptan vs. transdermal oestrogens or naproxen sodium for the prophylaxis of menstrual migraine. J Headache Pain 8:283–288

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Tassorelli C, Greco R, Allena M et al (2012) Transdermal hormonal therapy in perimenstrual migraine: why, when and how? Curr Pain Headache Rep 16:467–473

    Article  PubMed  Google Scholar 

  30. Calhoun A (2004) A novel specific prophylaxis for menstrually-associated migraine. South Med J 97:819–822

    Article  PubMed  Google Scholar 

  31. Edelman A, Gallo MF, Nichols MD, Jensen JT, Schulz KF, Grimes DA (2006) Continuous versus cyclic use of combined oral contraceptives for contraception: systematic Cochrane review of randomized controlled trials. Hum Reprod 21:573–578

    Article  CAS  PubMed  Google Scholar 

  32. Sulak P, Willis S, Kuehl T, Coffee A, Clark J (2007) Headaches and oral contraceptives: impact of eliminating the standard 7-day placebo interval. Headache 47:27–37

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Mount Sinai Roosevelt Hospital Center, The Headache Institute, 425 West 59th Street, New York, NY, 10019, USA

    L. C. Newman & M. S. Yugrakh

Authors
  1. L. C. Newman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. S. Yugrakh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. C. Newman.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Newman, L.C., Yugrakh, M.S. Menstrual migraine: treatment options. Neurol Sci 35 (Suppl 1), 57–60 (2014). https://doi.org/10.1007/s10072-014-1743-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-014-1743-3

Keywords

Search

Navigation